These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38915622)

  • 41. Epigenetic treatment of behavioral and physiological deficits in a tauopathy mouse model.
    Wang W; Cao Q; Tan T; Yang F; Williams JB; Yan Z
    Aging Cell; 2021 Oct; 20(10):e13456. PubMed ID: 34547169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
    Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
    Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin.
    Hu Y; Li XC; Wang ZH; Luo Y; Zhang X; Liu XP; Feng Q; Wang Q; Yue Z; Chen Z; Ye K; Wang JZ; Liu GP
    Oncotarget; 2016 Apr; 7(14):17356-68. PubMed ID: 26943044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alzheimer-like tau accumulation in dentate gyrus mossy cells induces spatial cognitive deficits by disrupting multiple memory-related signaling and inhibiting local neural circuit.
    Li S; Zhou Q; Liu E; Du H; Yu N; Yu H; Wang W; Li M; Weng Y; Gao Y; Pi G; Wang X; Ke D; Wang JZ
    Aging Cell; 2022 May; 21(5):e13600. PubMed ID: 35355405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Triggering receptor expressed on myeloid cells 2 deficiency exacerbates injury-induced inflammation in a mouse model of tauopathy.
    Katsumoto A; Kokiko-Cochran ON; Bemiller SM; Xu G; Ransohoff RM; Lamb BT
    Front Immunol; 2022; 13():978423. PubMed ID: 36389767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The human islet amyloid polypeptide reduces hippocampal tauopathy and behavioral impairments in P301S mice without inducing neurotoxicity or seeding amyloid aggregation.
    Yang YY; Ren YT; Jia MY; Bai CY; Liang XT; Gao HL; Zhong ML; Wang T; Guo C
    Exp Neurol; 2023 Apr; 362():114346. PubMed ID: 36750170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease-Associated Mutant Tau Prevents Circadian Changes in the Cytoskeleton of Central Pacemaker Neurons.
    Cassar M; Law AD; Chow ES; Giebultowicz JM; Kretzschmar D
    Front Neurosci; 2020; 14():232. PubMed ID: 32292325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau.
    Guo Q; Li H; Cole AL; Hur JY; Li Y; Zheng H
    PLoS One; 2013; 8(11):e80706. PubMed ID: 24278307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new metal ion chelator attenuates human tau accumulation-induced neurodegeneration and memory deficits in mice.
    Zuo Y; Liu HT; Lin LB; Yue RZ; Liu HH; Wang HW; Wang L; Hou RL; Liu WZ; Li CZ; Wang JZ; Li P; Yin YL
    Exp Neurol; 2024 Mar; 373():114657. PubMed ID: 38141802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clemastine fumarate attenuates tauopathy and meliorates cognition in hTau mice via autophagy enhancement.
    Zhu J; Jiang X; Chang Y; Wu Y; Sun S; Wang C; Zheng S; Wang M; Yao Y; Li G; Ma R
    Int Immunopharmacol; 2023 Oct; 123():110649. PubMed ID: 37494840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colocalization of BRCA1 with Tau Aggregates in Human Tauopathies.
    Kurihara M; Mano T; Saito Y; Murayama S; Toda T; Iwata A
    Brain Sci; 2019 Dec; 10(1):. PubMed ID: 31861888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
    van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
    Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy.
    Carroll JC; Iba M; Bangasser DA; Valentino RJ; James MJ; Brunden KR; Lee VM; Trojanowski JQ
    J Neurosci; 2011 Oct; 31(40):14436-49. PubMed ID: 21976528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The toxin MPTP generates similar cognitive and locomotor deficits in hTau and tau knock-out mice.
    Gratuze M; Josset N; Petry FR; Pflieger M; Eyoum Jong L; Truchetti G; Poitras I; Julien J; Bezeau F; Morin F; Samadi P; Cicchetti F; Bretzner F; Planel E
    Brain Res; 2019 May; 1711():106-114. PubMed ID: 30641037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss.
    Tackenberg C; Grinschgl S; Trutzel A; Santuccione AC; Frey MC; Konietzko U; Grimm J; Brandt R; Nitsch RM
    Cell Death Dis; 2013 Apr; 4(4):e608. PubMed ID: 23618906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology.
    Gratuze M; Julien J; Petry FR; Morin F; Planel E
    Sci Rep; 2017 Apr; 7():46359. PubMed ID: 28402338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis.
    Terron HM; Parikh SJ; Abdul-Hay SO; Sahara T; Kang D; Dickson DW; Saftig P; LaFerla FM; Lane S; Leissring MA
    Alzheimers Res Ther; 2024 Apr; 16(1):70. PubMed ID: 38575959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice.
    Maeda S; Djukic B; Taneja P; Yu GQ; Lo I; Davis A; Craft R; Guo W; Wang X; Kim D; Ponnusamy R; Gill TM; Masliah E; Mucke L
    EMBO Rep; 2016 Apr; 17(4):530-51. PubMed ID: 26931567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.